Targeting membrane fragility in LGMD R2 through pharmacological autophagy inductionNoëlla Grossi(Institut des Cellules Souches pour le Traitement et l'Étude des Maladies Monogéniques), Xavier Nissan(Inserm)Research SquareJuly 14, 202510.21203/rs.3.rs-6671973/v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersDrug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation|Cell Death and Disease|2016|52